Page last updated: 2024-11-12

cholecystokinin (26-32), tyr-gly-nle(28,31) phenethyl ester-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID16131167
MeSH IDM0184771

Synonyms (13)

Synonym
cck-ope
cholecystokinin (26-32), tyr-gly-nle(28,31) phenethyl ester-
cck (26-32), tyr-gly-nle(28,31) phenethyl ester-
119400-92-9
tyr-gly-28,31-nle-cck(28-32) phenethyl ester
tyrosyl-glycyl-aspartyl-sulfotyrosyl-norleucyl-glycyl-tryptophyl-norleucyl-aspartic acid 2-phenylethyl ester
cholecystokinin (26-32), tyrosyl-glycyl-norleucine(28,31) phenethyl ester-
tgn-cck-pee
cck(26-32), tyr-gly-nle(28,31) phenethyl ester-
d-tyr-gly-asp-tyr(so3)-nle-gly-trp-nle-asp-2-phenylethyl ester
l-aspartic acid, n-(n-(n-(n-(n-(o-sulfo-n-(n-(n-d-tyrosylglycyl)-l-alpha-aspartyl)-l-tyrosyl)-l-norleucyl)glycyl)-l-tryptophyl)-l-norleucyl)-, 1-(2-phenylethyl) ester
DTXSID40152451
(3s)-3-[[2-[[(2r)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-[[(2s)-3-carboxy-1-oxo-1-(2-phenylethoxy)propan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]am
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (76.92)18.2507
2000's3 (23.08)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]